Xylome is an industrial biotechnology solutions company
Xylome’s genetic tools, metabolic engineering and adaptive techniques can modify a range of unconventional yeast platforms for new metabolic pathways and the biosynthesis of advanced products such as Palm Oil Substitutes, Enzymes and Fish Meal Substitutes.
Unconventional yeasts have metabolic capabilities that go well beyond Saccharomyces in substrate utilization and product formation profiles. Our proprietary strains and genetic toolbox can enable more efficient formation of established products and open doors to novel biosyntheses.
Xylome’s proprietary strain of a native, non-GMO yeast that efficiently co-ferments glucose, xylose and cellobiose from a wide range of cellulosic hydrolysates and other organic waste streams
Contact Xylome to see how we can help with your microbial strain development programs
Xylome’s engineered lipogenic yeast for palm oil production
Xylome has engineered Lipomyces starkeyi for rapid, efficient production of a Palm Oil Substitute that can be used in a wide range of food, cosmetic and industrial applications.
Palm Oil Substitute
The world has been searching for a sustainable alternative for palm oil – and Xylome has it.
Xylome’s native xylose and cellobiose ethanologen:
SPCX-01 is ideal for add-on fermentations that can generate 60-70 g/L of ethanol from pentose sugars from ethanol plant by-products
Xylome’s process to generate a palm oil substitute ethanol plant by-products using Lipomyces starkeyi starch degrading enzymes
Xylome’s process to generate an omega-3 fish meal for aquaculture and animal feed purposes from ethanol plant by-products
Xylome is seeking strategic partners and/ or equity investors:
- Ideally, first adopter for demonstration projects
- Marketing/ commercialization leads for our technologies
Inquire about Xylome’s non-conventional yeasts that can be specifically tailored to your needs.
- Research licenses available
- Non-Disclosure and Material Transfer agreements required
- Commercial licenses based on product sales, royalties and sub-licensing agreements